Abeona Therapeutics (ABEO) Other Non-Current Assets (2010 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Other Non-Current Assets of $827000.0 for Q1 2026, up 1350.88% year-over-year from $57000.0 in Q1 2025, and up 5.89% quarter-over-quarter from $781000.0 in Q4 2025.
Abeona Therapeutics (ABEO) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $827000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 1350.88% year-over-year to $827000.0; the TTM figure through Mar 2026 stood at $827000.0 (up 1350.88% YoY), while the FY2025 annual figure was $781000.0, up 713.54% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $827000.0, up from $781000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $5.3 million in Q3 2022, with the low at $20000.0 in Q1 2022.
- The 5-year median for Other Non-Current Assets is $338000.0 (2022), against an average of $573588.2.
- The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets sank 98.27% in 2022, then jumped 1350.88% in 2026.
- Abeona Therapeutics' Other Non-Current Assets stood at $338000.0 in 2022, then dropped by 18.05% to $277000.0 in 2023, then tumbled by 65.34% to $96000.0 in 2024, then surged by 713.54% to $781000.0 in 2025, then grew by 5.89% to $827000.0 in 2026.
- Business Quant data shows ABEO's Other Non-Current Assets at $827000.0 in Q1 2026, $781000.0 in Q4 2025, and $338000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 827,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 827,000.00 |
| Mar 31, 2026 | 827,000.00 |
| Dec 31, 2025 | 781,000.00 |
| Sep 30, 2025 | 338,000.00 |
| Jun 30, 2025 | 338,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Sep 30, 2024 | 338,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 338,000.00 |
| Dec 31, 2023 | 277,000.00 |
| Sep 30, 2023 | 338,000.00 |
| Jun 30, 2023 | 108,000.00 |
| Mar 31, 2023 | 99,000.00 |
| Dec 31, 2022 | 338,000.00 |
| Sep 30, 2022 | 5.34 Mn |
| Jun 30, 2022 | 20,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Dec 31, 2021 | 5.89 Mn |
| Sep 30, 2021 | 1.16 Mn |